Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
UBE2V1 pseudogene 1 (UBE2V1P1)
- Target
- UBE2V1P1
- Molecular classification
- Other (pseudogene)
01
Overview
UBE2V1 pseudogene 1 (UBE2V1P1) is designated as a pseudogene related to the functional UBE2V1 gene, which encodes the ubiquitin-conjugating enzyme E2 variant 1[1][3]. Pseudogenes are genetic elements that have sequence similarity to functional genes but typically contain defects that prevent their expression or result in nonfunctional products. UBE2V1P1 does not encode a protein and has not been identified as a therapeutic target or as having a direct role in biological processes or disease mechanisms. Any therapeutic relevance, functional annotation, or drug interactions pertain to *UBE2V1*, not its pseudogene UBE2V1P1[1][3].
- Other names
- dJ687F11.3
Beyond the preview
Go deeper on UBE2V1 pseudogene 1 (UBE2V1P1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on UBE2V1 pseudogene 1 (UBE2V1P1).